CoChat

Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review

Sharma, Bhawana, Dabur, Rajesh · 2020 · Current Medicinal Chemistry
Cited by 125

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Background: Metabolic pathways perturbations lead to skeletal muscular atrophy in the cachexia and sarcopenia due to increased catabolism. Pro-inflammatory cytokines induce the catabolic pathways that impair the muscle integrity and function. Hence, this review primarily concentrates on the effects of pro-inflammatory cytokines in regulation of skeletal muscle metabolism. Objective: This review will discuss the role of pro-inflammatory cytokines in skeletal muscles during muscle wasting conditions. Moreover, the coordination among the pro-inflammatory cytokines and their regulated molecular signaling pathways which increase the protein degradation will be discussed. Results: During normal conditions, pro-inflammatory cytokines are required to balance anabolism and catabolism and to maintain normal myogenesis process. However, during muscle wasting their enhanced expression leads to marked destructive metabolism in the skeletal muscles. Proinflammatory cytokines primarily exert their effects by increasing the expression of calpains and E3 ligases as well as of Nf-κB, required for protein breakdown and local inflammation. Proinflammatory cytokines also locally suppress the IGF-1and insulin functions, hence increase the FoxO activation and decrease the Akt function, the central point of carbohydrates lipid and protein metabolism. Conclusion: Current advancements have revealed that the muscle mass loss during skeletal muscular atrophy is multifactorial. Despite great efforts, not even a single FDA approved drug is available in the market. It indicates the well-organized coordination among the pro-inflammatory cytokines that need to be further understood and explored.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/0929867326666181129095309

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 43 references

Research works printed but not linked: 182

  1. Kamei Y.; Miura S.; Suzuki M.; Kai Y.; Mizukami J.; Taniguchi T.; Mochida K.; Hata T.; Matsuda J.; Aburatani H.; Nishino I.; Ezaki O.; Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem 2004,279(39),41114-41123 · DOI · Paper page
  2. Lenk K.; Schuler G.; Adams V.; Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 2010,1(1),9-21 · DOI · Paper page
  3. Fanzani A.; Conraads V.M.; Penna F.; Martinet W.; Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle 2012,3(3),163-179 · DOI · Paper page
  4. Kandarian S.C.; Jackman R.W.; Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 2006,33(2),155-165 · DOI · Paper page
  5. Guimarães-Ferreira L.; Nicastro H.; Wilson J.; Zanchi N.E.; Skeletal muscle physiology. ScientificWorldJournal 2013,2013 · DOI
  6. Murton A.J.; Constantin D.; Greenhaff P.L.; The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy. Biochim Biophys Acta 2008,1782(12),730-743 · DOI · Paper page
  7. Bakkar N.; Ladner K.; Canan B.D.; Liyanarachchi S.; Bal N.C.; Pant M.; Periasamy M.; Li Q.; Janssen P.M.; Guttridge D.C.; IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. J Cell Biol 2012,196(4),497-511 · DOI · Paper page
  8. Dinarello C.A.; Proinflammatory cytokines. Chest 2000,118(2),503-508 · DOI · Paper page
  9. Späte U.; Schulze P.C.; Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 2004,7(3),265-269 · DOI · Paper page
  10. Argilés J.M.; Busquets S.; López-Soriano F.J.; The pivotal role of cytokines in muscle wasting during cancer. Int J Biochem Cell Biol 2005,37(10),2036-2046 · DOI
  11. Li H.; Malhotra S.; Kumar A.; Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl) 2008,86(10),1113-1126 · DOI · Paper page
  12. Feldman A.M.; Combes A.; Wagner D.; Kadakomi T.; Kubota T.; Li Y.Y.; McTiernan C.; The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000,35(3),537-544 · DOI · Paper page
  13. Niewczas M.A.; Gohda T.; Skupien J.; Smiles A.M.; Walker W.H.; Rosetti F.; Cullere X.; Eckfeldt J.H.; Doria A.; Mayadas T.N.; Warram J.H.; Krolewski A.S.; Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 2012,23(3),507-515 · DOI · Paper page
  14. Minkah B.; Pro-inflammatory cytokines as markers for the diagnosis of protein energy malnutrition 2010
  15. Ragheb R.; Shanab G.M.; Medhat A.M.; Seoudi D.M.; Adeli K.; Fantus I.G.; Free fatty acid-induced muscle insulin resistance and glucose uptake dysfunction: evidence for PKC activation and oxidative stress-activated signaling pathways. Biochem Biophys Res Commun 2009,389(2),211-216 · DOI
  16. Wei Y.; Chen K.; Whaley-Connell A.T.; Stump C.S.; Ibdah J.A.; Sowers J.R.; Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol Regul Integr Comp Physiol 2008,294(3),R673-R680 · DOI · Paper page
  17. Meshkani R.; Adeli K.; Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009,42(13-14),1331-1346 · DOI · Paper page
  18. Watson R.T.; Kanzaki M.; Pessin J.E.; Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes. Endocr Rev 2004,25(2),177-204 · DOI · Paper page
  19. Tomás E.; Lin Y.S.; Dagher Z.; Saha A.; Luo Z.; Ido Y.; Ruderman N.B.; Hyperglycemia and insulin resistance: possible mechanisms. Ann N Y Acad Sci 2002,967(1),43-51 · DOI · Paper page
  20. Björnholm M.; Zierath J.R.; Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans 2005,33(Pt 2),354-357 · DOI · Paper page
  21. Itani S.I.; Saha A.K.; Kurowski T.G.; Coffin H.R.; Tornheim K.; Ruderman N.B.; Glucose autoregulates its uptake in skeletal muscle: involvement of AMP-activated protein kinase. Diabetes 2003,52(7),1635-1640 · DOI · Paper page
  22. Koh H.J.; Regulation of exercise-stimulated glucose uptake in skeletal muscle. Ann Pediatr Endocrinol Metab 2016,21(2),61-65 · DOI
  23. Cani P.D.; Amar J.; Iglesias M.A.; Poggi M.; Knauf C.; Bastelica D.; Neyrinck A.M.; Fava F.; Tuohy K.M.; Chabo C.; Waget A.; Delmée E.; Cousin B.; Sulpice T.; Chamontin B.; Ferrières J.; Tanti J.F.; Gibson G.R.; Casteilla L.; Delzenne N.M.; Alessi M.C.; Burcelin R.; Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007,56(7),1761-1772 · DOI · Paper page
  24. Plomgaard P.; Bouzakri K.; Krogh-Madsen R.; Mittendorfer B.; Zierath J.R.; Pedersen B.K.; Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 2005,54(10),2939-2945 · DOI · Paper page
  25. Hommelberg P.P.; Langen R.C.; Schols A.M.; Mensink R.P.; Plat J.; Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention? Curr Opin Clin Nutr Metab Care 2010,13(6),647-655 · DOI
  26. Halse R.; Pearson S.L.; McCormack J.G.; Yeaman S.J.; Taylor R.; Effects of tumor necrosis factor-α on insulin action in cultured human muscle cells. Diabetes 2001,50(5),1102-1109 · DOI · Paper page
  27. Dong Y.; Dekens D.W.; De Deyn P.P.; Naude P.J.; Eisel U.L.; Targeting of tumor necrosis factor alpha receptors as a therapeutic strategy for neurodegenerative disorders. Antibodies (Basel) 2015,4(4),369-408 · DOI
  28. Chen N.J.; Chio I.I.C.; Lin W.J.; Duncan G.; Chau H.; Katz D.; Huang H.L.; Pike K.A.; Hao Z.; Su Y.W.; Yamamoto K.; de Pooter R.F.; Zúñiga-Pflücker J.C.; Wakeham A.; Yeh W.C.; Mak T.W.; Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci USA 2008,105(34),12429-12434 · DOI · Paper page
  29. Chen G.; Goeddel D.V.; TNF-R1 signaling: a beautiful pathway. Science 2002,296(5573),1634-1635 · DOI · Paper page
  30. Meylan E.; Burns K.; Hofmann K.; Blancheteau V.; Martinon F.; Kelliher M.; Tschopp J.; RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κ B activation. Nat Immunol 2004,5(5),503-507 · DOI · Paper page
  31. Cabal-Hierro L.; Rodríguez M.; Artime N.; Iglesias J.; Ugarte L.; Prado M.A.; Lazo P.S.; TRAF-mediated modulation of NF-kB AND JNK activation by TNFR2. Cell Signal 2014,26(12),2658-2666 · DOI
  32. Reid M.B.; Li Y.P.; Tumor necrosis factor-α and muscle wasting: a cellular perspective. Respir Res 2001,2(5),269-272 · DOI · Paper page
  33. Hall D.T.; Ma J.F.; Marco S.D.; Gallouzi I.E.; Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging (Albany NY) 2011,3(8),702-715 · DOI · Paper page
  34. De Paepe B.; De Bleecker J.L.; Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of Duchenne muscular dystrophy. Mediators Inflamm 2013,2013 · DOI · Paper page
  35. Ma J.F.; Sanchez B.J.; Hall D.T.; Tremblay A.K.; Di Marco S.; Gallouzi I.E.; STAT3 promotes IFNγ/TNFα-induced muscle wasting in an NF-κB-dependent and IL-6-independent manner. EMBO Mol Med 2017,9(5),622-637 · DOI · Paper page
  36. Zhang L.; Pan J.; Dong Y.; Tweardy D.J.; Dong Y.; Garibotto G.; Mitch W.E.; Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass. Cell Metab 2013,18(3),368-379 · DOI · Paper page
  37. Dagdeviren S.; Jung D.Y.; Lee E.; Friedline R.H.; Noh H.L.; Kim J.H.; Patel P.R.; Tsitsilianos N.; Tsitsilianos A.V.; Tran D.A.; Tsougranis G.H.; Kearns C.C.; Uong C.P.; Kwon J.Y.; Muller W.; Lee K.W.; Kim J.K.; Altered interleukin-10 signaling in skeletal muscle regulates obesity-mediated inflammation and insulin resistance. Mol Cell Biol 2016,36(23),2956-2966 · DOI · Paper page
  38. Hutchins A.P.; Diez D.; Miranda-Saavedra D.; The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Brief Funct Genomics 2013,12(6),489-498 · DOI · Paper page
  39. Walter M.R.; The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol 2014,380,191-212 · DOI
  40. Sato S.; Ogura Y.; Tajrishi M.M.; Kumar A.; Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. FASEB J 2015,29(3),988-1002 · DOI
  41. Lagathu C.; Yvan-Charvet L.; Bastard J.P.; Maachi M.; Quignard-Boulangé A.; Capeau J.; Caron M.; Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes. Diabetologia 2006,49(9),2162-2173 · DOI · Paper page
  42. Jager J.; Grémeaux T.; Cormont M.; Le Marchand-Brustel Y.; Tanti J.F.; Interleukin-1β-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007,148(1),241-251 · DOI · Paper page
  43. Kain V.; Kapadia B.; Viswakarma N.; Seshadri S.; Prajapati B.; Jena P.K.; Teja Meda C.L.; Subramanian M.; Kaimal Suraj S.; Kumar S.T.; Prakash Babu P.; Thimmapaya B.; Reddy J.K.; Parsa K.V.; Misra P.; Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4. Sci Rep 2015,5,15197 · DOI
  44. Lappas M.; Double stranded viral RNA induces inflammation and insulin resistance in skeletal muscle from pregnant women in vitro. Metabolism 2015,64(5),642-653 · DOI
  45. Aljada A.; Saadeh R.; Assian E.; Ghanim H.; Dandona P.; Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab 2000,85(7),2572-2575 · DOI
  46. Viollet B.; Lantier L.; Devin-Leclerc J.; Hebrard S.; Amouyal C.; Mounier R.; Foretz M.; Andreelli F.; Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci 2009,14,3380-3400 · DOI · Paper page
  47. Lontchi-Yimagou E.; Sobngwi E.; Matsha T.E.; Kengne A.P.; Diabetes mellitus and inflammation. Curr Diab Rep 2013,13(3),435-444 · DOI · Paper page
  48. Lowe G.; Woodward M.; Hillis G.; Rumley A.; Li Q.; Harrap S.; Marre M.; Hamet P.; Patel A.; Poulter N.; Chalmers J.; Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: the ADVANCE study. Diabetes 2014,63(3),1115-1123 · DOI · Paper page
  49. Perry B.D.; Caldow M.K.; Brennan-Speranza T.C.; Sbaraglia M.; Jerums G.; Garnham A.; Wong C.; Levinger P.; Asrar Ul Haq M.; Hare D.L.; Price S.R.; Levinger I.; Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev 2016,22,94-109
  50. Saponaro C.; Gaggini M.; Carli F.; Gastaldelli A.; The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 2015,7(11),9453-9474 · DOI · Paper page
  51. Omar B.; Zmuda-Trzebiatowska E.; Manganiello V.; Göransson O.; Degerman E.; Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis. Cell Signal 2009,21(5),760-766 · DOI · Paper page
  52. Li S.; Ogawa W.; Emi A.; Hayashi K.; Senga Y.; Nomura K.; Hara K.; Yu D.; Kasuga M.; Role of S6K1 in regulation of SREBP1c expression in the liver. Biochem Biophys Res Commun 2011,412(2),197-202 · DOI
  53. Chang Y.; Wang J.; Lu X.; Thewke D.P.; Mason R.J.; KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 2005,46(12),2624-2635 · DOI · Paper page
  54. Peterson T.R.; Sengupta S.S.; Harris T.E.; Carmack A.E.; Kang S.A.; Balderas E.; Guertin D.A.; Madden K.L.; Carpenter A.E.; Finck B.N.; Sabatini D.M.; mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011,146(3),408-420 · DOI · Paper page
  55. Li Y.; Xu S.; Mihaylova M.M.; Zheng B.; Hou X.; Jiang B.; Park O.; Luo Z.; Lefai E.; Shyy J.Y.J.; Gao B.; Wierzbicki M.; Verbeuren T.J.; Shaw R.J.; Cohen R.A.; Zang M.; AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 2011,13(4),376-388 · DOI · Paper page
  56. Costamagna D.; Costelli P.; Sampaolesi M.; Penna F.; Role of inflammation in muscle homeostasis and myogenesis. Mediators Inflamm 2015,2015 · DOI · Paper page
  57. Tan P.; Peng M.; Liu D.; Guo H.; Mai K.; Nian R.; Macq B.; Ai Q.; Suppressor of cytokine signaling 3 (SOCS3) is related to pro-inflammatory cytokine production and triglyceride deposition in turbot (Scophthalmus maximus). Fish Shellfish Immunol 2017,70,381-390 · DOI
  58. Xie P.; TRAF molecules in cell signaling and in human diseases. J Mol Signal 2013,8(1),7 · DOI · Paper page
  59. Dey P.; Panga V.; Raghunathan S.; A cytokine signalling network for the regulation of inducible nitric oxide synthase expression in rheumatoid arthritis. PLoS One 2016,11(9) · DOI
  60. Pina T.; Armesto S.; Lopez-Mejias R.; Genre F.; Ubilla B.; Gonzalez-Lopez M.A.; Gonzalez-Vela M.C.; Corrales A.; Blanco R.; Garcia-Unzueta M.T.; Hernandez J.L.; Llorca J.; Gonzalez-Gay M.A.; Anti-TNF-α therapy improves insulin sensitivity in non-diabetic patients with psoriasis: a 6-month prospective study. J Eur Acad Dermatol Venereol 2015,29(7),1325-1330 · DOI
  61. Babon J.J.; Varghese L.N.; Nicola N.A.; Inhibition of IL-6 family cytokines by SOCS3. Semin Immunol 2014,26(1),13-19 · DOI · Paper page
  62. Pang S.; Tang H.; Zhuo S.; Zang Y.Q.; Le Y.; Regulation of fasting fuel metabolism by toll-like receptor 4. Diabetes 2010,59(12),3041-3048 · DOI
  63. Glickman M.H.; Ciechanover A.; The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002,82(2),373-428 · DOI · Paper page
  64. Frisard M.I.; McMillan R.P.; Marchand J.; Wahlberg K.A.; Wu Y.; Voelker K.A.; Heilbronn L.; Haynie K.; Muoio B.; Li L.; Hulver M.W.; Toll-like receptor 4 modulates skeletal muscle substrate metabolism. Am J Physiol Endocrinol Metab 2010,298(5),E988-E998 · DOI · Paper page
  65. Rogero M.M.; Calder P.C.; Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients 2018,10(4),1-12 · DOI · Paper page
  66. Guadagnin E.; Mázala D.; Chen Y.W.; Stat3 in skeletal muscle function and disorders. Int J Mol Sci 2018,19(8),1-16 · DOI
  67. Barish G.D.; Downes M.; Alaynick W.A.; Yu R.T.; Ocampo C.B.; Bookout A.L.; Mangelsdorf D.J.; Evans R.M.; A nuclear receptor atlas: macrophage activation. Mol Endocrinol 2005,19(10),2466-2477 · DOI · Paper page
  68. Castrillo A.; Joseph S.B.; Vaidya S.A.; Haberland M.; Fogelman A.M.; Cheng G.; Tontonoz P.; Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 2003,12(4),805-816 · DOI · Paper page
  69. Gordon B.S.; Kelleher A.R.; Kimball S.R.; Regulation of muscle protein synthesis and the effects of catabolic states. Int J Biochem Cell Biol 2013,45(10),2147-2157 · DOI · Paper page
  70. Phillips R.S.; Enwonwu C.O.; Falkler W.A.; Pro- versus anti-inflammatory cytokine profile in African children with acute oro-facial noma (cancrum oris, noma). Eur Cytokine Netw 2005,16(1),70-77
  71. Nicastro H.; da Luz C.R.; Chaves D.F.; Bechara L.R.; Voltarelli V.A.; Rogero M.M.; Lancha A.H.; Does branched-chain amino acids supplementation modulate skeletal muscle remodeling through inflammation modulation? Possible mechanisms of action. J Nutr Metab 2012,2012 · DOI · Paper page
  72. Tisdale M.J.; Catabolic mediators of cancer cachexia. Curr Opin Support Palliat Care 2008,2(4),256-261 · DOI · Paper page
  73. Peterson J.M.; Bakkar N.; Guttridge D.C.; NF-κB signaling in skeletal muscle health and disease. Curr Top Dev Biol 2011,96(96),85-119 · DOI
  74. Patel H.J.; Patel B.M.; TNF-α and cancer cachexia: Molecular insights and clinical implications. Life Sci 2017,170,56-63 · DOI · Paper page
  75. Kadowaki M.; Kanazawa T.; Amino acids as regulators of proteolysis. J Nutr 2003,133(6)(Suppl. 1),2052S-2056S · DOI · Paper page
  76. Glass D.J.; Molecular mechanisms modulating muscle mass. Trends Mol Med 2003,9(8),344-350 · DOI · Paper page
  77. Goll D.E.; Thompson V.F.; Li H.; Wei W.; Cong J.; The calpain system. Physiol Rev 2003,83(3),731-801 · DOI · Paper page
  78. Huang J.; Zhu X.; The molecular mechanisms of calpains action on skeletal muscle atrophy. Physiol Res 2016,65(4),547-560 · DOI · Paper page
  79. Kramerova I.; Kudryashova E.; Tidball J.G.; Spencer M.J.; Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum Mol Genet 2004,13(13),1373-1388 · DOI · Paper page
  80. Richard I.; Roudaut C.; Marchand S.; Baghdiguian S.; Herasse M.; Stockholm D.; Ono Y.; Suel L.; Bourg N.; Sorimachi H.; Lefranc G.; Fardeau M.; Sébille A.; Beckmann J.S.; Loss of calpain 3 proteolytic activity leads to muscular dystrophy and to apoptosis-associated IkappaBalpha/nuclear factor kappaB pathway perturbation in mice. J Cell Biol 2000,151(7),1583-1590 · DOI · Paper page
  81. Tidball J.G.; Spencer M.J.; Calpains and muscular dystrophies. Int J Biochem Cell Biol 2000,32(1),1-5 · DOI
  82. Beckmann J.S.; Spencer M.; Calpain 3, the “gatekeeper” of proper sarcomere assembly, turnover and maintenance. Neuromuscul Disord 2008,18(12),913-921 · DOI
  83. Tidball J.G.; Spencer M.J.; Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 2002,545(3),819-828 · DOI · Paper page
  84. Smith I.J.; Lecker S.H.; Hasselgren P.O.; Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 2008,295(4),E762-E771 · DOI · Paper page
  85. Bartoli M.; Richard I.; Calpains in muscle wasting. Int J Biochem Cell Biol 2005,37(10),2115-2133 · DOI · Paper page
  86. Nelson W.B.; Smuder A.J.; Hudson M.B.; Talbert E.E.; Powers S.K.; Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation. Crit Care Med 2012,40(6),1857-1863 · DOI · Paper page
  87. Matsumoto A.; Fujita N.; Arakawa T.; Fujino H.; Miki A.; Influence of electrical stimulation on calpain and ubiquitin-proteasome systems in the denervated and unloaded rat tibialis anterior muscles. Acta Histochem 2014,116(5),936-942 · DOI
  88. Fareed M.U.; Evenson A.R.; Wei W.; Menconi M.; Poylin V.; Petkova V.; Pignol B.; Hasselgren P.O.; Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol 2006,290(6),R1589-R1597 · DOI · Paper page
  89. Purintrapiban J.; Wang M.C.; Forsberg N.E.; Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells. Comp Biochem Physiol B Biochem Mol Biol 2003,136(3),393-401 · DOI
  90. Yang H.; Menconi M.J.; Wei W.; Petkova V.; Hasselgren P.O.; Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPbeta in cultured myotubes. J Cell Biochem 2005,94(5),1058-1067 · DOI · Paper page
  91. Yang H.; Wei W.; Menconi M.; Hasselgren P.O.; Dexamethasone-induced protein degradation in cultured myotubes is p300/HAT dependent. Am J Physiol Regul Integr Comp Physiol 2007,292(1),R337-R4 · DOI · Paper page
  92. Ji J.; Su L.; Liu Z.; Critical role of calpain in inflammation. Biomed Rep 2016,5(6),647-652 · DOI
  93. Smith A.W.; Doonan B.P.; Tyor W.R.; Abou-Fayssal N.; Haque A.; Banik N.L.; Regulation of Th1/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients. J Neuroimmunol 2011,232(1-2),179-185 · DOI
  94. Iguchi-Hashimoto M.; Usui T.; Yoshifuji H.; Shimizu M.; Kobayashi S.; Ito Y.; Murakami K.; Shiomi A.; Yukawa N.; Kawabata D.; Nojima T.; Ohmura K.; Fujii T.; Mimori T.; Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals. PLoS One 2011,6(10) · DOI
  95. Pan H.C.; Yang C.N.; Hung Y.W.; Lee W.J.; Tien H.R.; Shen C.C.; Sheehan J.; Chou C.T.; Sheu M.L.; Reciprocal modulation of C/EBP-α and C/EBP-β by IL-13 in activated microglia prevents neuronal death. Eur J Immunol 2013,43(11),2854-2865 · DOI
  96. Yamamoto Y.; Gaynor R.B.; Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 2001,107(2),135-142 · DOI · Paper page
  97. Stalker T.J.; Gong Y.; Scalia R.; The calcium-dependent protease calpain causes endothelial dysfunction in type 2 diabetes. Diabetes 2005,54(4),1132-1140 · DOI
  98. Letavernier E.; Perez J.; Bellocq A.; Mesnard L.; de Castro Keller A.; Haymann J.P.; Baud L.; Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 2008,102(6),720-728 · DOI · Paper page
  99. Zhao Y.; Malinin N.L.; Meller J.; Ma Y.; West X.Z.; Bledzka K.; Qin J.; Podrez E.A.; Byzova T.V.; Regulation of cell adhesion and migration by Kindlin-3 cleavage by calpain. J Biol Chem 2012,287(47),40012-40020 · DOI
  100. Franco S.J.; Huttenlocher A.; Regulating cell migration: calpains make the cut. J Cell Sci 2005,118(Pt 17),3829-3838 · DOI · Paper page
  101. Cui Z.; Han Z.; Li Z.; Hu H.; Patel J.M.; Antony V.; Block E.R.; Su Y.; Involvement of calpain-calpastatin in cigarette smoke-induced inhibition of lung endothelial nitric oxide synthase. Am J Respir Cell Mol Biol 2005,33(5),513-520 · doi:10.1165/rcmb.2005-0046oc
  102. Dong Y.; Wu Y.; Wu M.; Wang S.; Zhang J.; Xie Z.; Xu J.; Song P.; Wilson K.; Zhao Z.; Lyons T.; Zou M.H.; Activation of protease calpain by oxidized and glycated LDL increases the degradation of endothelial nitric oxide synthase. J Cell Mol Med 2009,13(9A),2899-2910 · DOI
  103. Wang S.; Peng Q.; Zhang J.; Liu L.; Na/H exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain. Cardiovasc Res 2008,80(2),255-262 · DOI
  104. McClung J.M.; Judge A.R.; Talbert E.E.; Powers S.K.; Calpain-1 is required for hydrogen peroxide-induced myotube atrophy. Am J Physiol Cell Physiol 2009,296(2),C363-C371 · DOI · Paper page
  105. Dargelos E.; Brulé C.; Stuelsatz P.; Mouly V.; Veschambre P.; Cottin P.; Poussard S.; Up-regulation of calcium-dependent proteolysis in human myoblasts under acute oxidative stress. Exp Cell Res 2010,316(1),115-125 · DOI
  106. Siems W.; Capuozzo E.; Lucano A.; Salerno C.; Crifò C.; High sensitivity of plasma membrane ion transport ATPases from human neutrophils towards 4-hydroxy-2,3-trans-nonenal. Life Sci 2003,73(20),2583-2590 · DOI
  107. Oda A.; Wakao H.; Fujita H.; Calpain is a signal transducer and activator of transcription (STAT) 3 and STAT5 protease. Blood 2002,99(5),1850-1852 · DOI
  108. Wei W.; Yang H.; Cao P.; Menconi M.; Chamberlain C.; Petkova V.; Hasselgren P.O.; Degradation of C/EBPbeta in cultured myotubes is calpain-dependent. J Cell Physiol 2006,208(2),386-398 · DOI
  109. Chockalingam P.S.; Cholera R.; Oak S.A.; Zheng Y.; Jarrett H.W.; Thomason D.B.; Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy. Am J Physiol Cell Physiol 2002,283(2),C500-C511 · DOI
  110. Sneddon A.A.; Delday M.I.; Maltin C.A.; Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-α activity. Am J Physiol Endocrinol Metab 2000,279(1),E188-E195 · DOI
  111. Schulz R.A.; Yutzey K.E.; Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol 2004,266(1),1-16 · DOI · Paper page
  112. Horsley V.; Jansen K.M.; Mills S.T.; Pavlath G.K.; IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 2003,113(4),483-494 · DOI · Paper page
  113. Sato S.; Fujita N.; Tsuruo T.; Modulation of Akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 2000,97(20),10832-10837 · DOI · Paper page
  114. Smith I.J.; Dodd S.L.; Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp Physiol 2007,92(3),561-573 · DOI · Paper page
  115. Bartke T.; Pohl C.; Pyrowolakis G.; Jentsch S.; Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol Cell 2004,14(6),801-811 · DOI · Paper page
  116. Saini A.; Al-Shanti N.; Faulkner S.H.; Stewart C.E.; Pro- and anti-apoptotic roles for IGF-I in TNF-α-induced apoptosis: a MAP kinase mediated mechanism. Growth Factors 2008,26(5),239-253 · DOI · Paper page
  117. Li Y.P.; Chen Y.; Li A.S.; Reid M.B.; Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003,285(4),C806-C812 · DOI · Paper page
  118. Stupka N.; Tarnopolsky M.A.; Yardley N.J.; Phillips S.M.; Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol 2001,91(4),1669-1678 · DOI · Paper page
  119. Pickart C.M.; Back to the future with ubiquitin. Cell 2004,116(2),181-190 · DOI · Paper page
  120. Hunter R.B.; Stevenson E.; Koncarevic A.; Mitchell-Felton H.; Essig D.A.; Kandarian S.C.; Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J 2002,16(6),529-538 · DOI · Paper page
  121. Guttridge D.C.; Mayo M.W.; Madrid L.V.; Wang C.Y.; Baldwin A.S.; NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000,289(5488),2363-2366 · DOI · Paper page
  122. Gomes M.D.; Lecker S.H.; Jagoe R.T.; Navon A.; Goldberg A.L.; Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 2001,98(25),14440-14445 · DOI · Paper page
  123. Hasselgren P.O.; Fischer J.E.; Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 2001,233(1),9-17 · DOI · Paper page
  124. Sedger L.M.; McDermott M.F.; TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev 2014,25(4),453-472 · DOI · Paper page
  125. Sishi B.J.; Engelbrecht A.M.; Tumor necrosis factor alpha (TNF-α) inactivates the PI3-kinase/PKB pathway and induces atrophy and apoptosis in L6 myotubes. Cytokine 2011,54(2),173-184 · DOI
  126. Paul P.K.; Gupta S.K.; Bhatnagar S.; Panguluri S.K.; Darnay B.G.; Choi Y.; Kumar A.; Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol 2010,191(7),1395-1411 · DOI · Paper page
  127. Fitts R.H.; Riley D.R.; Widrick J.J.; Functional and structural adaptations of skeletal muscle to microgravity. J Exp Biol 2001,204(Pt 18),3201-3208 · DOI · Paper page
  128. Schieven G.L.; The biology of p38 kinase: a central role in inflammation. Curr Top Med Chem 2005,5(10),921-928 · DOI · Paper page
  129. Granado M.; Martín A.I.; Priego T.; López-Calderón A.; Villanúa M.A.; Tumour necrosis factor blockade did not prevent the increase of muscular muscle RING finger-1 and muscle atrophy F-box in arthritic rats. J Endocrinol 2006,191(1),319-326 · DOI
  130. Hunter R.B.; Kandarian S.C.; Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. J Clin Invest 2004,114(10),1504-1511 · DOI · Paper page
  131. Kwon Y.T.; Xia Z.; Davydov I.V.; Lecker S.H.; Varshavsky A.; Construction and analysis of mouse strains lacking the ubiquitin ligase UBR1 (E3α) of the N-end rule pathway. Mol Cell Biol 2001,21(23),8007-8021 · DOI · Paper page
  132. Combaret L.; Taillandier D.; Dardevet D.; Béchet D.; Rallière C.; Claustre A.; Grizard J.; Attaix D.; Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles. Biochem J 2004,378(Pt 1),239-246 · DOI · Paper page
  133. Kwon D.Y.; Motley W.W.; Fischbeck K.H.; Burnett B.G.; Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice. Hum Mol Genet 2011,20(18),3667-3677 · DOI
  134. Menconi M.; Gonnella P.; Petkova V.; Lecker S.; Hasselgren P.O.; Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes. J Cell Biochem 2008,105(2),353-364 · DOI · Paper page
  135. Dehoux M.; Van Beneden R.; Pasko N.; Lause P.; Verniers J.; Underwood L.; Ketelslegers J.M.; Thissen J.P.; Role of the insulin-like growth factor I decline in the induction of atrogin-1/MAFbx during fasting and diabetes. Endocrinology 2004,145(11),4806-4812 · DOI · Paper page
  136. Judge A.R.; Koncarevic A.; Hunter R.B.; Liou H.C.; Jackman R.W.; Kandarian S.C.; Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy. Am J Physiol Cell Physiol 2007,292(1),C372-C382 · DOI · Paper page
  137. Li Y.P.; Reid M.B.; NF-kappaB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 2000,279(4),R1165-R1170 · DOI · Paper page
  138. Whitehouse A.S.; Tisdale M.J.; Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation. Biochem Biophys Res Commun 2001,285(3),598-602 · DOI · Paper page
  139. Wang H.; Liu D.; Cao P.; Lecker S.; Hu Z.; Atrogin-1 affects muscle protein synthesis and degradation when energy metabolism is impaired by the antidiabetes drug berberine. Diabetes 2010,59(8),1879-1889 · DOI
  140. Crossland H.; Constantin-Teodosiu D.; Gardiner S.M.; Constantin D.; Greenhaff P.L.; A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 2008,586(22),5589-5600 · DOI · Paper page
  141. Dogra C.; Changotra H.; Wedhas N.; Qin X.; Wergedal J.E.; Kumar A.; TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 2007,21(8),1857-1869 · DOI · Paper page
  142. Winkles J.A.; The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 2008,7(5),411-425 · DOI · Paper page
  143. Bhatnagar S.; Kumar A.; The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting. Curr Mol Med 2012,12(1),3-13 · DOI · Paper page
  144. Foulstone E.J.; Huser C.; Crown A.L.; Holly J.M.; Stewart C.E.; Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha. Exp Cell Res 2004,294(1),223-235 · DOI
  145. Langen R.C.; Schols A.M.; Kelders M.C.; van der Velden J.L.; Wouters E.F.; Janssen-Heininger Y.M.; Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation. Am J Respir Cell Mol Biol 2006,35(6),689-696 · DOI · Paper page
  146. Dogra C.; Changotra H.; Wergedal J.E.; Kumar A.; Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J Cell Physiol 2006,208(3),575-585 · DOI · Paper page
  147. Enwere E.K.; Holbrook J.; Lejmi-Mrad R.; Vineham J.; Timusk K.; Sivaraj B.; Isaac M.; Uehling D.; Al-awar R.; LaCasse E.; Korneluk R.G.; TWEAK and cIAP1 regulate myoblast fusion through the noncanonical NF-κB signaling pathway. Sci Signal 2012,5(246),ra75 · DOI · Paper page
  148. Girgenrath M.; Weng S.; Kostek C.A.; Browning B.; Wang M.; Brown S.A.; Winkles J.A.; Michaelson J.S.; Allaire N.; Schneider P.; Scott M.L.; Hsu Y.M.; Yagita H.; Flavell R.A.; Miller J.B.; Burkly L.C.; Zheng T.S.; TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J 2006,25(24),5826-5839 · DOI · Paper page
  149. Ogura Y.; Mishra V.; Hindi S.M.; Kuang S.; Kumar A.; Proinflammatory cytokine tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) suppresses satellite cell self-renewal through inversely modulating Notch and NF-κB signaling pathways. J Biol Chem 2013,288(49),35159-35169 · DOI
  150. Sato S.; Ogura Y.; Kumar A.; TWEAK/Fn14 signaling axis mediates skeletal muscle atrophy and metabolic dysfunction. Front Immunol 2014,5,18 · DOI · Paper page
  151. Fan J.; Kou X.; Yang Y.; Chen N.; MicroRNA-regulated pro-inflammatory cytokines in sarcopenia. Mediators Inflamm 2016,2016 · DOI
  152. Klionsky D.J.; Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007,8(11),931-937 · DOI · Paper page
  153. Kon M.; Cuervo A.M.; Chaperone-mediated autophagy in health and disease. FEBS Lett 2010,584(7),1399-1404 · DOI · Paper page
  154. Arndt V.; Dick N.; Tawo R.; Dreiseidler M.; Wenzel D.; Hesse M.; Fürst D.O.; Saftig P.; Saint R.; Fleischmann B.K.; Hoch M.; Höhfeld J.; Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol 2010,20(2),143-148 · DOI · Paper page
  155. Crotzer V.L.; Blum J.S.; Autophagy and intracellular surveillance: Modulating MHC class II antigen presentation with stress. Proc Natl Acad Sci USA 2005,102(22),7779-7780 · DOI
  156. Rajawat Y.S.; Hilioti Z.; Bossis I.; Aging: central role for autophagy and the lysosomal degradative system. Ageing Res Rev 2009,8(3),199-213 · DOI · Paper page
  157. Bach M.; Larance M.; James D.E.; Ramm G.; The serine/threonine kinase ULK1 is a target of multiple phosphorylation events. Biochem J 2011,440(2),283-291 · DOI · Paper page
  158. Momeni H.R.; Role of calpain in apoptosis. Cell J 2011,13(2),65-72
  159. Brechtel K.; Dahl D.B.; Machann J.; Bachmann O.P.; Wenzel I.; Maier T.; Claussen C.D.; Häring H.U.; Jacob S.; Schick F.; Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 2001,45(2),179-183 · doi:10.1002/1522-2594(200102)45:2<179:aid-mrm1023>3.0.co;2-d
  160. Ge Y.; Huang M.; Yao Y.M.; Autophagy and proinflammatory cytokines: Interactions and clinical implications. Cytokine Growth Factor Rev 2018,43,38-46 · DOI · Paper page
  161. Wang Y.; Li T.; Wu B.; Liu H.; Luo J.; Feng D.; Shi Y.; STAT1 regulates MD-2 expression in monocytes of sepsis via miR-30a. Inflammation 2014,37(6),1903-1911 · DOI
  162. Buchser W.J.; Laskow T.C.; Pavlik P.J.; Lin H.M.; Lotze M.T.; Cell-mediated autophagy promotes cancer cell survival. Cancer Res 2012,72(12),2970-2979 · DOI · Paper page
  163. Park H.J.; Lee S.J.; Kim S.H.; Han J.; Bae J.; Kim S.J.; Park C.G.; Chun T.; IL-10 inhibits the starvation induced autophagy in macrophages via class I phosphatidylinositol 3-kinase (PI3K) pathway. Mol Immunol 2011,48(4),720-727 · DOI
  164. Van Grol J.; Subauste C.; Andrade R.M.; Fujinaga K.; Nelson J.; Subauste C.S.; HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 2010,5(7) · DOI · Paper page
  165. Martinez-Outschoorn U.E.; Whitaker-Menezes D.; Lin Z.; Flomenberg N.; Howell A.; Pestell R.G.; Lisanti M.P.; Sotgia F.; Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011,10(11),1784-1793 · DOI · Paper page
  166. Wu T.T.; Li W.M.; Yao Y.M.; Interactions between autophagy and inhibitory cytokines. Int J Biol Sci 2016,12(7),884-897 · DOI · Paper page
  167. Sharma G.; Dutta R.K.; Khan M.A.; Ishaq M.; Sharma K.; Malhotra H.; Majumdar S.; IL-27 inhibits IFN-γ induced autophagy by concomitant induction of JAK/PI3 K/Akt/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages. Int J Biochem Cell Biol 2014,55,335-347 · DOI
  168. Jia G.; Cheng G.; Gangahar D.M.; Agrawal D.K.; Insulin-like growth factor-1 and TNF-α regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunol Cell Biol 2006,84(5),448-454 · DOI · Paper page
  169. Ye Y.C.; Yu L.; Wang H.J.; Tashiro S.; Onodera S.; Ikejima T.; TNFα-induced necroptosis and autophagy via supression of the p38-NF-κB survival pathway in L929 cells. J Pharmacol Sci 2011,117(3),160-169 · DOI
  170. Zhang M.; Kenny S.J.; Ge L.; Xu K.; Schekman R.; Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. eLife 2015,4(e11205),1-23 · doi:10.7554/elife.11205.002
  171. Xu B.; Bai B.; Sha S.; Yu P.; An Y.; Wang S.; Kong X.; Liu C.; Wei N.; Feng Q.; Zhao Q.; Interleukin-1β induces autophagy by affecting calcium homeostasis and trypsinogen activation in pancreatic acinar cells. Int J Clin Exp Pathol 2014,7(7),3620-3631
  172. Shen J.; Xu S.; Zhou H.; Liu H.; Jiang W.; Hao J.; Hu Z.; IL-1β induces apoptosis and autophagy via mitochondria pathway in human degenerative nucleus pulposus cells. Sci Rep 7(41067), 1-12.2017 · DOI
  173. Chang C.P.; Yang M.C.; Lei H.Y.; Concanavalin A/IFN-gamma triggers autophagy-related necrotic hepatocyte death through IRGM1-mediated lysosomal membrane disruption. PLoS One 2011,6(12) · DOI
  174. Matsuzawa T.; Kim B.H.; Shenoy A.R.; Kamitani S.; Miyake M.; Macmicking J.D.; IFN-γ elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol 2012,189(2),813-818 · DOI · Paper page
  175. Yuan J.; Yu M.; Li H.H.; Long Q.; Liang W.; Wen S.; Wang M.; Guo H.P.; Cheng X.; Liao Y.H.; Autophagy contributes to IL-17-induced plasma cell differentiation in experimental autoimmune myocarditis. Int Immunopharmacol 2014,18(1),98-105 · DOI
  176. Liu H.; Mi S.; Li Z.; Hua F.; Hu Z.W.; Interleukin 17A inhibits autophagy through activation of PIK3CA to interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial cells. Autophagy 2013,9(5),730-742 · DOI · Paper page
  177. Zhou Y.; Wu P.W.; Yuan X.W.; Li J.; Shi X.L.; Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2016,20(2),250-263
  178. Sims J.E.; Smith D.E.; The IL-1 family: regulators of immunity. Nat Rev Immunol 2010,10(2),89-102 · DOI · Paper page
  179. Gao Y.; Ma L.; Luo C.L.; Wang T.; Zhang M.Y.; Shen X.; Meng H.H.; Ji M.M.; Wang Z.F.; Chen X.P.; Tao L.Y.; IL-33 exerts neuroprotective effect in mice intracerebral hemorrhage model through suppressing inflammation/apoptotic/autophagic pathway. Mol Neurobiol 2017,54(5),3879-3892 · DOI
  180. Gao Y.; Luo C.L.; Li L.L.; Ye G.H.; Gao C.; Wang H.C.; Huang W.W.; Wang T.; Wang Z.F.; Ni H.; Chen X.P.; IL-33 provides neuroprotection through suppressing apoptotic, autophagic and NF-κB-mediated inflammatory pathways in a rat model of recurrent neonatal seizure. Front Mol Neurosci 2017,10((423), 1-12.) · DOI
  181. Gabay C.; Towne J.E.; Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions. J Leukoc Biol 2015,97(4),645-652 · DOI · Paper page
  182. Dutt V.; Gupta S.; Dabur R.; Injeti E.; Mittal A.; Skeletal muscle atrophy: Potential therapeutic agents and their mechanisms of action. Pharmacol Res 2015,99,86-100 · DOI · Paper page

Cited by

See all 125

Metadata

Authors
Sharma, B., & Dabur, R.
Venue
Current Medicinal Chemistry
Published
2020-04-24
Volume
27
Issue
13
Pages
2161-2188
ISSN
0929-8673 (ISSN-L)
OpenAlex
W2902699183
Cited by
125
References
43
FWCI
0.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review. https://app.cochat.ai/papers/10.2174/0929867326666181129095309
The paper
Sharma, B., & Dabur, R. (2020). Role of Pro-inflammatory Cytokines in Regulation of Skeletal Muscle Metabolism: A Systematic Review. Current Medicinal Chemistry. https://doi.org/10.2174/0929867326666181129095309

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.